ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Evaluation and characterization of HSPA5 (GRP78) expression profiles in normal individuals and cancer patients with COVID-19

Fu, Jiewen; Wei, Chunli; He, Jiayue; Zhang, Lianmei; Zhou, Ju; Balaji, Kyathegowdanadoddi Srinivasa; Shen, Shiyi; Peng, Jiangzhou*; Sharma, Amrish*; Fu, Junjiang南方医科大学; 1
International Journal of Biological Sciences2021DOI: 10.7150/ijbs.54055
27被引2阅读
引用收藏
分享

摘要

HSPA5 (BiP, GRP78) has been reported as a potential host-cell receptor for SARS-Cov-2, but its expression profiles on different tissues including tumors, its susceptibility to SARS-Cov-2 virus and severity of its adverse effects on malignant patients are unclear. In the current study, HSPA5 has been found to be expressed ubiquitously in normal tissues and significantly increased in 14 of 31 types of cancer tissues. In lung cancer, mRNA levels of HSPAS were 253-fold increase than that of ACE2. Meanwhile, in both malignant tumors and matched normal samples across almost all cancer types, mRNA levels of HSPAS were much higher than those of ACE2. Higher expression of HSPAS significantly decreased patient overall survival (OS) in 7 types of cancers. Moreover, systematic analyses found that 7.15% of 5,068 COVID-19 cases have malignant cancer coincidental situations, and the rate of severe events of COVID-19 patients with cancers present a higher trend than that for all COVID-19 patients, showing a significant difference (33.33% vs 16.09%, p<0.01). Collectively, these data imply that the tissues with high HSPA5 expression, not low ACE2 expression, are susceptible to be invaded by SARS-CoV-2. Taken together, this study not only indicates the clinical significance of HSPA5 in COVID-19 disease and cancers, but also provides potential clues for further medical treatments and managements of COVID-19 patients.

学科与关键词

关键词
cancerHSPA5prognosticsSARS-CoV-2transcriptomics
相关
加载中…
  • High expression of ACE2 and TMPRSS2 and clinical characteristics of COVID-19 in colorectal cancer patients
    Liu, Chao; Wang, Kai; Zhang, Min; Hu, Xiaoyu; Hu, Tian; Liu, Yumei; Hu, Qinyong*; Wu, Shikai*; Yue, Jinbo*npj Precision Oncology, 2021, 5(1): 1.被引 29
  • High Expression of ACE2 and TMPRSS2 at the Resection Margin Makes Lung Cancer Survivors Susceptible to SARS-CoV-2 With Unfavorable Prognosis
    Wang, Qianqian; Li, Liangyu; Qu, Tianyu; Li, Jie; Wu, Lingxiang; Li, Kening; Wang, Ziyu; Zhu, Mengyan; Huang, Bin; Wu, Wei; Wu, Min; Ding, Rong; Zhang, Zhihong; Wang, Qianghu; Xia, Xinyi*; Li, Pengping*; Zhang, Zhi; Guo, Renhua*Frontiers in Oncology, 2021, 11: 644575.被引 11
  • Landscape Profiling Analysis of DPP4 in Malignancies: Therapeutic Implication for Tumor Patients With Coronavirus Disease 2019
    Shu, Lingling*; Liu, Yang; Li, Jinyuan; Wu, Xiaoping; Li, Yang; Huang, HanyingFrontiers in Oncology, 2021, 11: 624899.被引 12
查看全部 →

发表信息

论文状态
公开发表
期刊
International Journal of Biological Sciences
发表日期
2021
卷期
第 17 卷, 第 3 期
页码
897-910
DOI
10.7150/ijbs.54055
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81672887, 30371493]; Joint Research Foundation of Luzhou City [2018LZXNYD-YL01]; Translational Medicine Foundation of Southwest Medical University [00031476, 00031477]; Southwest Medical University [2018LZXNYD-YL01]

作者

  • F

    Fu, Jiewen (第一作者)

  • W

    Wei, Chunli

查看全部 10 位作者收起作者
  • H

    He, Jiayue

  • Z

    Zhang, Lianmei

    1 · nanjing med univ

  • Z

    Zhou, Ju

  • B

    Balaji, Kyathegowdanadoddi Srinivasa

  • S

    Shen, Shiyi

  • P

    Peng, Jiangzhou (通讯)

    southern med univ

  • S

    Sharma, Amrish (通讯)

  • F

    Fu, Junjiang

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417